The Cooper Companies, Inc.
COO
Classifica tra le azioni
#1886
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Prezzo delle azioni
$59.03
Ultima sincronizzazione: 2026-10-20
Capitalizzazione di mercato
$11.23B
Variazione (1 giorno)
1.50%
Variazione (1 anno)
-21.29%
Paese
US
Scambia The Cooper Companies, Inc. (COO)
Categoria
Healthcare
Ricavi di The Cooper Companies, Inc. (COO)
Ricavi nel Jul 2026 TTM: $4.24B
Secondo gli ultimi rapporti finanziari di The Cooper Companies, Inc., i ricavi attuali dell'azienda (TTM) sono pari a $4.24B. Nel 2024, l'azienda ha registrato ricavi di $3.90B un aumento rispetto a i ricavi dell'anno 2023, che erano pari a $3.59B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per The Cooper Companies, Inc. da 2000 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $4.24B | 3.53% |
| 2025 | $4.09B | 5.06% |
| 2024 | $3.90B | 8.41% |
| 2023 | $3.59B | 8.61% |
| 2022 | $3.31B | 13.20% |
| 2021 | $2.92B | 20.22% |
| 2020 | $2.43B | -8.39% |
| 2019 | $2.65B | 4.76% |
| 2018 | $2.53B | 18.41% |
| 2017 | $2.14B | 8.75% |
| 2016 | $1.97B | 9.45% |
| 2015 | $1.80B | 4.62% |
| 2014 | $1.72B | 8.19% |
| 2013 | $1.59B | 9.87% |
| 2012 | $1.45B | 8.59% |
| 2011 | $1.33B | 14.87% |
| 2010 | $1.16B | 7.23% |
| 2009 | $1.08B | 1.62% |
| 2008 | $1.06B | 11.84% |
| 2007 | $950.64M | 10.67% |
| 2006 | $858.96M | 6.49% |
| 2005 | $806.62M | 64.56% |
| 2004 | $490.18M | 19.04% |
| 2003 | $411.79M | 30.60% |
| 2002 | $315.31M | 34.42% |
| 2001 | $234.57M | 18.88% |
| 2000 | $197.32M | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $11.03B | 160.43% |
US
|
|
| $34.74B | 719.84% |
FR
|
|
| - | - |
JP
|
|
| $20.84B | 391.83% |
US
|
|
| - | - |
CH
|
